share_log

Roth MKM Initiates Coverage On Unity Biotechnology With Buy Rating, Announces Price Target of $10

Benzinga ·  May 31, 2023 04:27

Roth MKM analyst Dylan Dupuis initiates coverage on Unity Biotechnology (NASDAQ:UBX) with a Buy rating and announces Price Target of $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment